drugset / Trial / NCT01987167
Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis
NaSingle-groupOpen-labelTreatment
Summary
The goal of the study is to determine the earliest structural changes in the optic nerve during the acute event and during the twelve months of recovery following Acthar treatment.
Timeline
- Start
- 2013-11
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acthar | Peptide | 40 iu | Subcutaneous |